Xanthine oxidase-IN-14
Xanthine oxidase-IN-14 (Compound 3f) is an inhibitor for xanthine oxidase, with IC50 >100 μM. Xanthine oxidase-IN-14 inhibits proliferations of cancer cells MCF-7, NCI-H460 and SF-268, with IC50 greater than 150 μM[1].
Product Specifications
CAS Number
[80025-67-8]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Xanthine Oxidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xanthine-oxidase-in-14.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C(N)N(C2=CC=C(C(F)(F)F)C=C2)N=C1
Molecular Formula
C11H7F3N4
Molecular Weight
252.20
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Gupta S, et al., Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors. Eur J Med Chem. 2008 Apr;43 (4) :771-80.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0066805 3x 1.0 µg
AKAP14 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details S1013-33B-ML490 100 µL
SH3 and PX domain-containing protein 2B (SH3PXD2B, Factor for adipocyte differentiation 49, SH3 and PX domains 2B, Factor for adipocyte differentiation 49, Fad49, KIAA1295) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
GTR15111226 1 Vial
Lentiviral human PKP4 shRNA (UAS) - Lentiviral human PKP4 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details